IDO1 and depressive symptom measurement: Although tryptophan supplementation has been used to treat depression (DeVane, 1998), such an approach would be unlikely to be effective where there is cancer-related IDO induction, because this would increase IDO-associated neurotoxic metabolites – such as quinolinic acid (Saito et al, 1992).